Literature DB >> 24308711

Antibiotic-lock therapy: a clinical viewpoint.

Nuria Fernández-Hidalgo1, Benito Almirante.   

Abstract

Antibiotic lock therapy (ALT) - instillation of high concentrations of anti-microbial agent with or without anti-coagulant into the lumen of central venous catheters - is considered a valid conservative treatment for catheter-related bloodstream infection (CRBSI) in patients highly dependent on maintaining the catheter. Results from randomized controlled studies have indicated that the effectiveness of ALT is moderate, but recent findings from experimental studies and observational case series point to considerable efficacy and safety of this therapy, which is usually associated with concomitant systemic treatment. In this article, the current knowledge about ALT for patients with CRBSI is reviewed and discussed, with emphasis on existing controversies and the results obtained according to the various uses of the catheters and the etiologies of infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308711     DOI: 10.1586/14787210.2014.863148

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  9 in total

1.  Understanding biofilm formation in intravascular device-related infections.

Authors:  Christophe Beloin; Nuria Fernández-Hidalgo; David Lebeaux
Journal:  Intensive Care Med       Date:  2016-08-06       Impact factor: 17.440

2.  Antibiofilm Activity of Electrical Current in a Catheter Model.

Authors:  Paul Voegele; Jon Badiola; Suzannah M Schmidt-Malan; Melissa J Karau; Kerryl E Greenwood-Quaintance; Jayawant N Mandrekar; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

Review 4.  Prevention and treatment of Staphylococcus aureus biofilms.

Authors:  Mohini Bhattacharya; Daniel J Wozniak; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Expert Rev Anti Infect Ther       Date:  2015-11-13       Impact factor: 5.091

Review 5.  Strategies for combating bacterial biofilm infections.

Authors:  Hong Wu; Claus Moser; Heng-Zhuang Wang; Niels Høiby; Zhi-Jun Song
Journal:  Int J Oral Sci       Date:  2015-03-23       Impact factor: 6.344

6.  In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

Authors:  Diego Parra; Alejandro Peña-Monje; Nieves María Coronado-Álvarez; José Hernández-Quero; Jorge Parra-Ruiz
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

7.  Eradication of P. aeruginosa biofilm in endotracheal tubes based on lock therapy: results from an in vitro study.

Authors:  María Jesús Pérez-Granda; María Consuelo Latorre; Beatriz Alonso; Javier Hortal; Rafael Samaniego; Emilio Bouza; María Guembe
Journal:  BMC Infect Dis       Date:  2017-12-04       Impact factor: 3.090

8.  Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants.

Authors:  Hong Liang; Lian Zhang; Xiaoping Guo; Li Sun
Journal:  BMC Pediatr       Date:  2021-01-04       Impact factor: 2.125

9.  A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains.

Authors:  Raquel Ferrer-Espada; Hawraa Shahrour; Betsey Pitts; Philip S Stewart; Susana Sánchez-Gómez; Guillermo Martínez-de-Tejada
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.